top of page
Pricing & Negotiations & Reimbursement
In the context of mergers, acquisitions, or portfolio evaluations, Glogger Consulting delivers rapid and high-impact analyses of pricing and reimbursement potential for pharmaceutical assets in the EU. These assessments are tailored to support strategic decision-making under tight timelines, offering an independent and expert external perspective.In addition extensive support for price negotations and reimbursement questions is part of this portfolio.
Pricing: pricing expectations / evaluations corresponding to HTA basis including evaluation of mitigation strategies. Exploring contracting strategies fitting commercial strategy including stakeholder mapping/ engagement
​
Price negotiations focus on Germany (according to §130 SGB V): strategy development/ sparrings partner ideally early and prior to launch. Leading negotiations on behalf of a company and supporting price negotiations with GKV-SV.
​
Reimbursement environment: Advisory on national and regional reimbursement frameworks, including opportunities and barriers.
Example cases:
bottom of page